Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary^†

Area of Science:

• Molecular oncology
• Cancer genomics
• Tumor suppressor gene function

Background:

• Gene disruption via double-strand DNA breaks inactivates tumor suppressor TP53, notably in osteosarcoma and biliary adenocarcinoma.
• Intron breakpoint patterns in TP53 do not correlate with prevalence, intron length, or genome-wide rearrangement levels, suggesting selection for other reasons.
• A recent study in The Journal of Pathology investigated the functional implications of TP53 intron 1 breakpoints.

Purpose of the Study:

• To elucidate the functional consequences of TP53 intron 1 breakpoints in osteosarcoma.
• To investigate whether TP53 promoter relocation drives oncogenic programs.
• To present a new paradigm for oncogenesis involving both tumor suppressor loss and oncogenic gain-of-function.

Main Methods:

• Analysis of high-quality matched genomic and transcriptomic osteosarcoma sequencing data.
• In vitro validation experiments.
• Characterization of TP53 promoter region relocation and its downstream effects.

Main Results:

• Rearrangements involving TP53 intron 1 relocate the TP53 promoter region.
• The relocated promoter upregulates genes involved in cartilage and growth plate development, osteoclast formation, and TP53-related pathways.
• These upregulation events represent gain-of-function, promoting tumor development and growth.

Conclusions:

• TP53 intron breakpoints can lead to gain-of-function events, promoting oncogenesis.
• This mechanism presents a novel paradigm where a single mutation results in both loss of tumor suppression and activation of an oncogenic program.
• Findings have implications for understanding osteosarcoma and biliary adenocarcinoma development and potential therapeutic strategies.